Skip to main content
. 2022 Aug 9;144(4):747–765. doi: 10.1007/s00401-022-02478-5

Fig. 3.

Fig. 3

Kaplan–Meier curves comparing glioma-specific survival (a) and progression-free survival (b) for the 47 NF1 patients stratified by molecular low-grade versus high-grade groups